|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20.11.26 - 00:00
|
US panel warns of China′s biotech rise, fuelling push to curb ties as Chinese firms unfazed (SCMP)
|
|
|
Fresh warnings from a US congressional advisory body about the rapid rise of China's biopharmaceutical sector are fuelling Washington's push to curb cross-border ties, analysts said, though China's industry appears largely unfazed.
China was gaining a “competitive advantage” in biopharmaceuticals, and Western firms were increasingly paying large upfront fees to license Chinese drugs thanks to the country's “growing innovative capacity”, the US-China Economic and Security Review Commission (USCC)......
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
19.11.26 - 11:00
|
RA Capital opens Shanghai office to tap Chinese biotech even as US investment rules tighten (SCMP)
|
|
|
Prominent healthcare-focused US venture capital firm RA Capital has expanded its China footprint with a new Shanghai office, aiming to tap innovation in the Chinese biotech ecosystem as US firms navigate Washington's escalating scrutiny of cross-border deals.
Boston-headquartered RA Capital now has 12 China-based staff members, including four investment professionals who started working in the country in the past few months, partner Josh Resnick said in an interview on Wednesday.
The firm's new......
|
|
|
|
|
|
|
|